Published in Pol Tyg Lek on April 04, 1966
Effects of fenofibrate on plasma cytokine concentrations in patients with atherosclerosis and hyperlipoproteinemia IIb. Int J Clin Pharmacol Ther (1998) 1.10
Serum HDL cholesterol concentration in patients with squamous cell and small cell lung cancer. Int J Mol Med (2000) 0.97
Immunoglobulins and complement components levels in patients with lung cancer. Rom J Intern Med (1992) 0.89
Serum total cholesterol and triglycerides levels in patients with lung cancer. Int J Mol Med (2000) 0.87
Effects of micronized fenofibrate on insulin resistance in patients with metabolic syndrome. Int J Clin Pharmacol Ther (2004) 0.85
Plasma selenium concentration in patients with stomach and colon cancer in the Upper Silesia. Neoplasma (1997) 0.81
Effects of fenofibrate and simvastatin on plasma sICAM-1 and MCP-1 concentrations in patients with hyperlipoproteinemia. Int J Clin Pharmacol Ther (2003) 0.81
Effects of atorvastatin, simvastatin, and fenofibrate therapy on monocyte chemoattractant protein-1 secretion in patients with hyperlipidemia. Eur J Clin Pharmacol (2003) 0.79
Effects of fibrates on plasma prothrombotic activity in patients with type IIb dyslipidemia. Int J Clin Pharmacol Ther (2001) 0.77
Fibronectin gene polymorphism in patients with lung cancer. Oncol Rep (2001) 0.77
[Serum levels of immunoglobulins and C 3 component of complement in persons occupationally exposed to chlorinated pesticides]. Med Pr (1985) 0.77
A new immunological marker of atherosclerotic injury of arterial wall. Res Commun Mol Pathol Pharmacol (2001) 0.76
[Levels of tumor necrosis factor alpha in serum of patients with hyperlipoproteinemia IIB before and after micronized fenofibrate therapy]. Pol Arch Med Wewn (1998) 0.76
Changes in the metabolism and functions of peripheral blood neutrophils in patients with thyroid diseases. Endokrynol Pol (1984) 0.76
[T-lymphocytes and their T-gamma and T-mu subpopulations in cigarette smokers]. Pol Arch Med Wewn (1981) 0.76
Levels of sICAM-1, sVCAM-1 and MCP-1 in patients with hyperlipoproteinemia IIa and -IIb. Int J Clin Pharmacol Ther (2001) 0.76
Low-dose zinc administration as an effective Wilson's disease treatment. Biol Trace Elem Res (2001) 0.76
[Cholecystolithiasis in the urban population of Poland]. Pol Arch Med Wewn (1995) 0.76
Plasma cytokines as predictors of coronary heart disease. Res Commun Mol Pathol Pharmacol (2002) 0.76
The risk of atherosclerosis in patients with impaired glucose tolerance. Res Commun Mol Pathol Pharmacol (2003) 0.75
[A case of hystiocytosis X with clinical manifestations of constrictive pericarditis]. Pol Tyg Lek (1970) 0.75
[Use of balance rheometry in the dynamic surveys of sputum viscosity and elasticity]. Pneumonol Pol (1980) 0.75
Quality of life in cancer patients treated by chemotherapy. Neoplasma (2000) 0.75
[Cytochemical studies of peripheral blood granulocytes after occupational exposure to pesticides]. Pol Tyg Lek (1981) 0.75
[Primary forms of extralymphatic non-Hodgkin's lymphoma]. Pol Tyg Lek (1996) 0.75
[Evaluation of the indicators of nitroblue tetrazolium reduction by the peripheral blood granulocytes of patients with thyroid diseases]. Pol Tyg Lek (1980) 0.75
[Diagnostic difficulties in a case of a perihepatic pseudocyst]. Wiad Lek (1982) 0.75
[Spasm syndrome of the postbulbar part of the duodenum in the course of oophoritis]. Pol Tyg Lek (1969) 0.75
Alimentary chylomicronemia in cases of liver cirrhosis. Pol Med J (1969) 0.75
[Alimentary chylomicronemia in liver cirrhosis]. Pol Tyg Lek (1969) 0.75
[Test with protamine sulfate in fibrinolytic treatment of myocardial infarct]. Pol Arch Med Wewn (1973) 0.75
[Evaluation of ambulatory treatment of advanced forms of Hodgkin's disease with special reference to psychological, social and economic aspects]. Pol Tyg Lek (1992) 0.75
[A case of multiple recurrences of idiopathic pericarditis]. Wiad Lek (1970) 0.75
[Activity of various lysosomal enzymes in the peripheral blood leukocytes in hyperthyroidism]. Pol Tyg Lek (1980) 0.75
[A case of eosinophilic lung infiltrations with fatal outcome]. Wiad Lek (1968) 0.75
[Primary liver carcinoma as a complication of liver cirrhosis]. Pol Arch Med Wewn (1970) 0.75
[2 cases of tumors of the left heart atrium]. Wiad Lek (1971) 0.75
[Arylsulfatase of peripheral blood leukocytes in patients with selected proliferative diseases of the hematopoietic system, malignant neoplasms in other organs and lupus erythematosus]. Pol Arch Med Wewn (1984) 0.75
[Studies of small intestine mocosa during x-ray therapy applied to abdomen]. Pol Tyg Lek (1971) 0.75
[Ormond's fibrosis, bone osteolysis and stomach intramural metastases in the course f low-differentiated prostatic cancer]. Pol Arch Med Wewn (2001) 0.75
[A case of malignant melanoma of the stomach and intestine]. Wiad Lek (1969) 0.75
[Elasticity and various biochemical sputum components in patients with asthma]. Pneumonol Pol (1980) 0.75
[The problem of the association of ulcer of the stomach and duodenum and secretion of blood group substances into the gastric contents]. Pol Arch Med Wewn (1966) 0.75
[Various rheological properties of blood in tobacco smokers]. Pol Tyg Lek (1982) 0.75
Evaluation of metabolism of connective tissue proteins in patients with lung cancer. Acta Biochim Pol (1992) 0.75
The distribution of certain enzymes in normal mucosa of the human small intestine. Pol Med J (1968) 0.75
Alimentary chylomicronemia and gastric acidity. Pol Med J (1969) 0.75
[Kay's test and gastric mucosa biopsy in Addison's disease]. Pol Tyg Lek (1973) 0.75
[2 cases of agranulocytosis in patients treated with levamisole]. Pol Tyg Lek (1981) 0.75
[Angiotensin infusion test in liver cirrhosis]. Pol Arch Med Wewn (1971) 0.75
[Various histoenzymatic reactions in the colonic mucosa in ulcerative colitis]. Pol Tyg Lek (1978) 0.75
[Gastrological problems in Addison's disease]. Pol Tyg Lek (1971) 0.75
[Ormond's syndrome--idiopathic retroperitoneal fibrosis]. Pol Tyg Lek (1970) 0.75
[Total thyroxine, triiodothyronine-binding index and free thyroxine index in patients with malignant neoplasms]. Pol Arch Med Wewn (1980) 0.75
The influence of angiotensin converting enzyme inhibitors on lipid peroxidation in sera and aorta of rabbits in diet-induced hypercholesterolemia. Int J Mol Med (2000) 0.75
[Polyneuropathy in liver cirrhosis. Clinical and electrophysiological assessment]. Neurol Neurochir Pol (1974) 0.75
[Assessment of adrenal gland reserve in patients with ulcerative colitis]. Pol Tyg Lek (1977) 0.75
[Transcutaneous stimulation of the heart ventricles: its effectiveness, comfort during the examination and new diagnostic possibility]. Kardiol Pol (1989) 0.75
[The influence of angiotensin-converting enzyme inhibitors on collagen content of the aorta wall in experimental hypercholesterolemia]. Przegl Lek (1999) 0.75
[Anti-elastin antibodies in systemic lupus erythematosus]. Pol Tyg Lek (1991) 0.75
[Starvation and liver cirrhosis (Observation of former prisoners of war]. Pol Arch Med Wewn (1968) 0.75
[2 cases of nonparasitic cysts of the liver]. Pol Tyg Lek (1969) 0.75
[Prevention of systemic lupus erythematosus]. Pol Tyg Lek (1988) 0.75
[Histochemical studies of human gastric mucosa]. Pol Tyg Lek (1971) 0.75
[Effect of soybean oil in the diet on the degree of idiopathic hyperlipemia]. Wiad Lek (1968) 0.75
[Hypertrophic gastropathy]. Pol Tyg Lek (1969) 0.75
[Anabolic action of small doses of antibiotics]. Pol Tyg Lek (1973) 0.75
[Effect of antibiotics on the activity of pancreatic enzymes in vitro]. Pol Arch Med Wewn (1971) 0.75
[Prevention of systemic lupus erythematosus in children born to mothers treated for this disease]. Pol Tyg Lek (1990) 0.75
[Results of combined therapy in patients with nonseminomatous testicular tumors]. Pol Tyg Lek (1990) 0.75
[Use of histologic examination of the bone marrow in the differential diagnosis of polycythemia]. Wiad Lek (1988) 0.75
[Alimentary chylomicronemia and gastric acidity]. Pol Tyg Lek (1968) 0.75
[Effect of dipyridamole on various rheological properties of the blood in arteriosclerosis]. Pol Tyg Lek (1981) 0.75
[Modified method of angiotensin test]. Pol Arch Med Wewn (1971) 0.75
[Unusual case of diaphragmatic hernia]. Pol Tyg Lek (1970) 0.75
[Nitroblue tetrazolium reduction test (NBT) in patients with hyperthyroidism]. Pol Tyg Lek (1978) 0.75
Serum LDL cholesterol concentration and lipoprotein electrophoresis pattern in patients with small cell lung cancer. Int J Mol Med (2000) 0.75
[Gastric acidity in liver cirrhosis]. Pol Tyg Lek (1968) 0.75
[Value of ultrasonographic examination in monitoring the treatment of advanced cancer of the stomach]. Pol Przegl Radiol (1989) 0.75
[Postbulbar duodenal spasm syndrome]. Pol Tyg Lek (1965) 0.75
Anti-elastin antibodies in patients with lung cancer. Immunol Lett (1992) 0.75
[Attempted treatment of dermatomyositis with disodium versanate]. Wiad Lek (1968) 0.75
[Practical importance of small intestine biopsy]. Pol Tyg Lek (1971) 0.75
[Peripheral nerve conduction in workers of the cadmium division of non-iron metallurgical plants]. Pol Tyg Lek (1981) 0.75
[Clinical evaluation of the preparation Obracin]. Wiad Lek (1982) 0.75
The influence of angiotensin-converting enzyme inhibitors on the aorta elastin metabolism in diet-induced hypercholesterolaemia in rabbits. J Renin Angiotensin Aldosterone Syst (2001) 0.75
[Excretion of blood group substances in gastric contents in patients with stomach cancer]. Pol Arch Med Wewn (1967) 0.75
A new chemotherapeutic regimen in the treatment of advanced gastric cancer. Neoplasma (1990) 0.75
[Intestinal lipodystrophy]. Pol Tyg Lek (1972) 0.75
Biopsy of small intestinal mucosa in patients after partial resection of the stomach. Pol Med J (1968) 0.75
Investigations on the in vitro effect of antibiotics on the activity of the pancreatic enzymes. Pol Med J (1972) 0.75
[Multiple primary neoplasms]. Wiad Lek (1989) 0.75
[Value of hypotonic duodenography in the diagnosis of certain diseases of the digestive tract]. Wiad Lek (1966) 0.75
[Distribution of certain enzymes in the normal mucosa of the human small intestine]. Pol Arch Med Wewn (1967) 0.75
[Effect of smoking on various hematological values]. Wiad Lek (1979) 0.75
Elastin metabolism parameters in sera of patients with lung cancer. Neoplasma (1993) 0.75
[Blood groups in certain diseases of the gastrointestinal tract, arteriosclerosis and rheumatic disease]. Pol Arch Med Wewn (1968) 0.75